Saliva point-of-care testing for suboptimal levofloxacin and linezolid exposure in multidrug-resistant tuberculosis.

Saved in:
Bibliographic Details
Title: Saliva point-of-care testing for suboptimal levofloxacin and linezolid exposure in multidrug-resistant tuberculosis.
Authors: Nguyen TA; Faculty of Medicine and Health, The University of Sydney, Sydney, Australia.; Department of Pharmacy, Westmead Hospital, Parramatta, Australia.; Sydney Infectious Diseases Institute, The University of Sydney, Sydney, Australia., Nguyen AT; Faculty of Medicine and Health, The University of Sydney, Sydney, Australia.; Woolcock Institute of Medical Research, Hanoi, Vietnam.; The University of Sydney Vietnam Institute, Ho Chi Minh City, Vietnam., Dinh LV; National Lung Hospital, Hanoi, Vietnam., Nguyen HB; National Lung Hospital, Hanoi, Vietnam., Vu HD; National Drug Information and Adverse Drug Reactions Monitoring Centre, Hanoi University of Pharmacy, Hanoi, Vietnam., Nguyen TNB; Woolcock Institute of Medical Research, Hanoi, Vietnam.; The University of Sydney Vietnam Institute, Ho Chi Minh City, Vietnam., Vu D; Woolcock Institute of Medical Research, Hanoi, Vietnam.; The University of Sydney Vietnam Institute, Ho Chi Minh City, Vietnam., Punt NC; University Medical Centre Groningen, Groningen, The Netherlands.; Medimatics, Maastricht, The Netherlands., Fox GJ; Faculty of Medicine and Health, The University of Sydney, Sydney, Australia.; Sydney Infectious Diseases Institute, The University of Sydney, Sydney, Australia.; Royal Prince Alfred Hospital, Camperdown, Australia., Stocker SL; Faculty of Medicine and Health, The University of Sydney, Sydney, Australia.; Department of Pharmacy, Westmead Hospital, Parramatta, Australia.; Sydney Infectious Diseases Institute, The University of Sydney, Sydney, Australia.; School of Clinical Medicine, The University of New South Wales, Australia.; Department of Clinical Pharmacology and Toxicology, St Vincent's Hospital, Darlinghurst, Australia., Alffenaar JC; Faculty of Medicine and Health, The University of Sydney, Sydney, Australia johannes.alffenaar@sydney.edu.au.; Department of Pharmacy, Westmead Hospital, Parramatta, Australia.; Sydney Infectious Diseases Institute, The University of Sydney, Sydney, Australia.
Source: The European respiratory journal [Eur Respir J] 2026 Jun 12; Vol. 67 (6). Date of Electronic Publication: 2026 Jun 12 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: European Respiratory Society Country of Publication: England NLM ID: 8803460 Publication Model: Electronic-Print Cited Medium: Internet ISSN: 1399-3003 (Electronic) Linking ISSN: 09031936 NLM ISO Abbreviation: Eur Respir J Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1399-3003
DOI:10.1183/13993003.01875-2025